Today's Top Gainer
Note:Top Gainer - Nifty 50 More
Nov 09,2019 12:43 PM
Dr. Lal PathLabs recorded 41.48% jump in consolidated profit after tax to Rs 80.50 crore on 15.15% increase in revenues to Rs 365.
Dr Lal Pathlabs Ltd leads losers in A group Nov 01,2019
Dr. Lal PathLabs to hold board meeting Oct 19,2019
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Apollo Hospitals Enterprise Ltd||1,390.45||58.10||19,373.16||90.60||0.43||2,463.58||266.78|
|Dr Lal Pathlabs Ltd||1,548.25||56.65||12,866.28||79.50||0.39||351.20||124.96|
|Fortis Healthcare Ltd||135.00||14.50||10,191.94||-13.27||0.00||181.40||116.85|
|Aster DM Healthcare Ltd||149.15||149.44||7,474.84||-4.34||0.00||200.60||58.79|
|Metropolis Healthcare Ltd||1,292.40||55.59||6,502.40||31.68||1.02||172.28||92.41|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Dr. Lal PathLabs has built a national, hub and ... More
Dec 12, 2019 12:58 AM
The company’s consolidated revenue stood at Rs292.50cr, up 11.34% yoy but down 7.87% qoq.
08 Nov 2019
20 Nov 2019
Dr. Lal PathLabs Ltd has informed BSE that the Board of Directors of the Company at its meeting held... More
08 Nov 2019
18 Oct 2019
Interim Dividend & Quarterly ResultsDear Sir/Madam,Please take note that the Board of Directors in t... More